Journal
PLOS ONE
Volume 13, Issue 9, Pages -Publisher
PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0203713
Keywords
-
Categories
Funding
- Independent Research Fund Denmark
- Novo Nordisk Foundation
- Danish Diabetes Association
- DesireAe and Niels Yde Foundation
- A.P. Moller Foundation
- Poul and Erna Sehested Hansen Foundation
- Sven Hansen and wife Ina Hansen Foundation
- Danish Strategic Research Council, Center for non-coding RNA in Technology and Health
- commercial company Novo Nordisk A/S
- Novo Nordisk A/S
Ask authors/readers for more resources
Inflammatory beta-cell failure contributes to type 1 and type 2 diabetes pathogenesis. Pro-inflammatory cytokines cause beta-cell dysfunction and apoptosis, and lysine deacetylase inhibitors (KDACi) prevent beta-cell failure in vitro and in vivo, in part by reducing NF-kappa B transcriptional activity. We investigated the hypothesis that the protective effect of KDACi involves transcriptional regulation of microRNAs (miRs), potential new targets in diabetes treatment. Insulin-producing INS1 cells were cultured with or without the broad-spectrum KDACi Givinostat, prior to exposure to the pro-inflammatory cytokines IL-1 beta and IFN-gamma for 6 h or 24 h, and miR expression was profiled with miR array. Thirteen miRs (miR-7a-2-3p, miR-29c-3p, miR-96-5p, miR-101a-3p, miR-140-5p, miR-146a-5p, miR-146b-5p, miR-340-5p, miR-384-5p, miR-455-5p, miR-466b-2-3p, miR-652-5p, and miR-3584-5p) were regulated by both cytokines and Givinostat, and nine were examined by qRT-PCR. miR-146a-5p was strongly regulated by cytokines and KDACi and was analyzed further. miR-146a-5p expression was induced by cytokines in rat and human islets. Cytokine-induced miR-146a5p expression was specific for INS1 and beta-TC3 cells, whereas alpha-TC1 cells exhibited a higher basal expression. Transfection of INS1 cells with miR-146a-5p reduced cytokine signaling, including the activity of NF-kappa B and iNOS promoters, as well as NO production and protein levels of iNOS and its own direct targets TNF receptor associated factor 6 (TRAF6) and interleukin-1 receptor-associated kinase 1 (IRAK1). miR-146a-5p was elevated in the pancreas of diabetes-prone BB-DP rats at diabetes onset, suggesting that miR-146a-5p could play a role in type 1 diabetes development. The miR array of cytokine-exposed INS1 cells rescued by KDACi revealed several other miRs potentially involved in cytokine-induced beta-cell apoptosis, demonstrating the strength of this approach.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available